Transient Splenial Lesion of the Corpus Callosum in Clinically Mild Influenza-Associated Encephalitis/Encephalopathy

N. Bulakbasi; M. Kocaoglu; C. Tayfun; T. Ucoz

Abstract

BACKGROUND: Reversible lesions in the splenium of the corpus callosum (SCC), caused by various agents such as influenza, rotavirus, Escherichia coli, mumps, and adenovirus, were previously defined in a handful of cases. We present 5 cases with transient diffusion restriction of the SCC associated with influenza A virus infection.

MATERIALS AND METHODS: Five patients with influenza-associated encephalitis/encephalopathy and sudden-onset neurologic symptoms following a prodromal flulike episode were examined by MR and diffusion-weighted imaging (DWI).

RESULTS: Three patients, who had drowsiness and new-onset convulsions, recovered spontaneously without any medication. In the other 2 seizure-free patients, 1 had trigeminal neuralgia and headache and the other had facial numbness and left upper monoparesis. All patients had round well-defined ovoid hyperintense splenial lesions (14.94 ± 1.87 mm) on DWI with a significantly low apparent diffusion coefficient (ADC) of 0.41 ± 0.05 × 10⁻³ mm²/s compared with 0.84 ± 0.01 × 10⁻³ mm²/s of normal-appearing white matter. In the patient with a motor deficit, additional lesions were found in the cerebral deep white matter. The high signal intensity of the splenial and deep white matter lesions on DWI completely disappeared on follow-up studies, and ADC values also improved, returning to those of normal-appearing white matter on days 8–11. Clinically, all patients completely recovered on days 4–9.

CONCLUSION: A transient lesion of the SCC is a significant but nonspecific finding. It is probably due to edematous and/or inflammatory changes of the SCC. It may be the only detectable change in patients with good prognosis, indicating a clinically mild form of encephalitis/encephalopathy.

Influenza A is the most common upper respiratory tract infectious agent causing flulike symptoms.¹ It is especially widespread in winter seasons and can cause epidemics.^1–3 Besides Reye syndrome⁴ and hemorrhagic shock and encephalopathy syndromes,⁵ it can occasionally cause rapid progressive encephalopathy with high fever, alteration of cognition, and convulsion, which is called influenza-associated encephalitis/encephalopathy (IAEE), including acute necrotizing encephalopathy.^1–3,6–8 IAEE is more common and has a poorer prognosis in children than in adults.^1,2,9 In clinically mild IAEEs, neurologic symptoms can recover quickly, usually without any specific medication.

The previously described brain lesions in patients with IAEE include restricted diffusion involving the cerebral cortex and subcortical white matter in various localizations; symmetric lesions in the brain stem, basal ganglia, thalamus, and cerebellar white matter with or without brain edema; and mild brain atrophy.^3,10–12 Transient restricted diffusion of the splenium of the corpus callosum (SCC) in patients with IAEE was also well defined in previous articles.^13,14 However, it is not specific to IAEE and has been reported secondary to various infectious agents, including rotavirus,¹⁵ measles,¹⁶ herpesvirus 6,¹⁷ Salmonella organisms,¹⁸ mumps,¹⁴ varicella-zoster virus,¹⁴ adenovirus,¹⁴ O157 Escherichia coli–associated hemolytic-uremic syndrome,¹⁹ Legionnaires’ disease,²⁰ and unknown pathogens.^14,21 Neither the exact pathophysiology nor the specific site predilection of transient SCC lesions was clear. The most possible causes of these transient lesions of the SCC have been explained as rapidly resolving intramyelinic edema or the influx of inflammatory cells and macromolecules, combined with related cytotoxic edema.^13,14

In this study, we describe the imaging findings of 5 patients with IAEE and transient diffusion restriction of the SCC and discuss the possible pathogenesis of these lesions in view of previous reports.

Methods

Patient Population

Five patients, including 3 men and 2 women, ranging from 6 to 41 years of age (mean age, 22.2 ± 12.07 years), with sudden-onset neurologic symptoms following a prodromal flulike episode, underwent contrast-enhanced MR and diffusion-weighted imaging (DWI) to rule out meningoencephalitis. The beginning of the flulike symptoms was taken as day 1, and initiation and resolution of all neurologic symptoms and radiologic findings were expressed in time increments from day 1. Initial MR imaging examinations were performed 2–4 hours after admission to hospital. Patients did not have any medication, especially corticosteroids or antiepileptic drugs, before the MR imaging. The IAEE diagnosis was confirmed by the isolation of influenza A virus from their throat swabs. Follow-up MR imaging in all patients was performed by the same protocol on days 8–11. Informed consent was obtained from all patients for MR imaging studies and for review of patients’ records and images.

All patients were examined by a 1.5T superconducting MR scanner (The New Intera Nova, Philips Medical Systems, Best, the Netherlands) by using a standard quadrature head coil. Axial T1-weighted (TR/TE, 583/15 ms; 1 excitation) spin-echo (SE), T2-weighted (TR/TE, 2295/90 ms; 2 excitations) turbo SE, and fast fluid-attenuated inversion recovery (FLAIR; TR/TE/TI, 8000/100/2000 ms; 1 excitation) images were obtained by using 5-mm section thickness with 1-mm intersection gap and a 256 × 256 matrix size. After intravenous administration of 0.2 mg/kg of gadodiamide (Omniscan), contrast-enhanced T1-weighted SE sequences were also obtained in 3 orthogonal planes.

DWI was performed by using an axial multisection single-shot echo-planar SE sequence (TE, 91 ms; shortest TR ranging from 4200 to 4300 ms; 1 excitation; 1833.3 Hz/pixel bandwidth; echo-planar factor, 89; 22 sections with 5-mm section thickness without intersection gap; matrix size,112 × 256; field of view, 220 × 220 mm in 29.5 seconds). The apparent diffusion coefficient (ADC) maps were calculated on a pixel-by-pixel basis. Standard mean ADC values of each region of interest from lesions and normal-appearing white matter were calculated automatically and expressed in 10⁻³ mm²/s.

Results

All patients were previously healthy and had no history of seizure, usage of antiepileptic drugs, or any type of vaccination during the last 2 years. Neurologic symptoms became prominent on days 2–5 after the initiation of a prodromal flu episode and high fever (40.3 ± 0.6°C). The new-onset convulsions (on days 2–4) occurred in 3 patients before being admitted to the hospital and resolved spontaneously without any medication. These 3 patients also had drowsiness and some abnormality on electroencephalography. In the other 2 seizure-free patients, 1 had trigeminal neuralgia and headache (on day 2) and the other had facial numbness and left upper monoparesis (on day 5). Rapid-onset neurologic symptoms following a prodromal flu episode were typical for IAEE. In all patients, influenza A virus was isolated from their throat swabs, allowing the diagnosis of IAEE. The influenza genome was not detected in any of their CSF by polymerase chain reaction. Clinically, all patients were completely recovered on days 4–9. The results of blood count, routine biochemistry, and CSF analysis of all patients were in normal limits during illness.

Initial MR imaging examination of each patient was performed on the day that his or her neurologic symptoms developed (on days 2–5). All patients had significant transient lesions in the SCC on their initial MR images (Figs 1A, -C, -E and 2A–C). Lesions were well defined, ovoid, and centrally located in the SCC. The mean diameter of splenial lesions was 14.94 ± 1.87 mm. They were slightly hyperintense on FLAIR and T2-weighted images (Figs 1A, -B and 2A) but not detectable on T1-weighted images. No lesions were enhanced on postcontrast images. All lesions were prominently more hyperintense on isotropic DWI than on T2-weighted and FLAIR images (Figs 1C, -D and 2B). They had significantly lower signal intensity and ADC values (0.41 ± 0.05 × 10⁻³ mm²/s) than those of normal-appearing white matter (0.84 ± 0.01 × 10⁻³ mm²/s) (Figs 1E, -F and 2C) on ADC map images. In 1 patient who had mild motor deficits, there were additional lesions in the cerebral deep white matter (Fig 1B,-D, -F). No other signal intensity or diffusion change was detected in the other patients.

Fig 1.

Patient 1 (21 years old) with IAEE and sudden onset of facial numbness and left upper monoparesis on day 5. A, Axial T2-weighted image shows a hyperintense well-defined and circumscribed splenial lesion (arrowheads). B, Axial T2-weighted image through the supraventricular region shows patchy high signal intensity of deep white matter lesions (arrows). C and D, Splenial (arrowheads) and deep white matter (arrows) lesions have higher signal intensity on isotropic DWI than those on T2-weighted images. E and F, ADC map images reveal significant restricted diffusion with reduced ADC values obtained from 3 regions of interest of splenial and white matter lesions (0.42 ± 10⁻³ mm²/s, 0.47 ± 10⁻³ mm²/s, and 0.51 ± 10⁻³ mm²/s). G and H, Follow-up isotropic DWI on day 11 shows the reversal of diffusion restriction in both splenial and white matter lesions.

Fig 2.

Patient 4 (6 years old) with IAEE and fever and sudden-onset convulsion on day 3. A, Single ovoid well-defined splenial lesion (arrowheads) is slightly hyperintense on the T2-weighted axial image. B, The lesion (arrowheads) has prominently high signal intensity on isotropic DWI. C, ADC value of 0.34 ± 10⁻³ mm²/s obtained from the region of interest located in the lesion reveals restricted diffusion on ADC map image. D, Follow-up study on day 9 shows complete resolution of diffusion restriction on isotropic DWI.

Follow-up examinations were performed on days 8–11. The high signal intensity of all lesions on DWI disappeared (Figs 1G, -H and 2D), and their ADC values (0.81 ± 0.04 × 10⁻³ mm²/s) were recovered to normal-appearing white matter (0.84 ± 0.01 × 10⁻³ mm²/s).

Discussion

IAEE is a complex clinical syndrome, including both encephalitis and encephalopathy.^1,6 When there is no evidence of inflammatory change, the term “encephalopathy” is used instead.¹⁴ There is probably a continuum and/or an overlap between these clinical syndromes,^1,2 so they are generally named together. The onset of neurologic symptoms is usually within a few days to a week after the first signs of influenza A infection and complete recovery occurs within a month as in our patients.^1–3,9,14 The clinical findings of our patients were similar to results of previous reports,^{1,3,9,13,14,22} except those of trigeminal neuralgia. This might be the consequence of a viral route of entry to the brain, because the trigeminal nerve is one of the most promising neuronal pathways of virus within the olfactory nerve.^23,24Motor deficits, seen in our 1 patient, were probably due to deep white matter lesions rather than to the splenial lesion itself.

The CSF analyses results of all our patients were within normal limits and free of virus antigens by polymerase chain reaction. The CSF analyses of patients with IAEE often reveal lack of pleocytosis or merely a discrete elevation of mononuclear leukocytes. Protein and glucose contents are usually normal,²⁵ though a slightly increased protein level may be present.¹ Positive CSF virus isolation is very rare,^10,26,27 either owing to the disappearance of the virus by the time of sampling or to undetectably low amounts of virus in the CSF.^1,25

The pathogenesis of IAEE is not clear because of a lack of pathologic correlation in mild forms of the disease. The autopsy findings are mainly from the results of necrotizing encephalopathy (ie, the clinically worst form of IAEE). Autopsy results show that the integrity of the blood-brain barrier (BBB) seems to be an important prognostic factor,¹⁰ and the disruption of the BBB promotes neuronal degeneration with severe clinical findings. A toxin-mediated aberrant immune activation²³ causing endothelial injury, microvascular angiopathy and perivascular edema,^19,20,28,29 or inflammatory cytokine release from virus-stimulated glial cells causing rapid breakdown of the BBB^23,25,29,30 can be responsible for the neurotoxic effect. However, direct viral invasion of neurons can also occur, because a positive influenza antigen has been reported in brain tissue.^1,25 The clinical severity of IAEE can be moderated by the degree of immune competence of the host, virulence of the agent, route of entry, and coexistence of other predisposing factors such as age, previous vaccination, hypoglycemia, electrolyte imbalance, vitamin deficiency, or seizures.^{1,17,23,30,31}

In the mild form of IAEE, the reversal of restricted diffusion and lack of any significant enhancement without fulminant brain edema suggest a limited direct invasion of neurons, which is not sufficient to cause an immunologic response with resultant rapid breakdown of the BBB. The cytotoxic edema seen in acute cellular energy failure, such as acute arterial infarction, can possibly be the cause of decreased ADC values,^12,15 because cytotoxic edema is hardly ever reversible. Intramyelinic edema due to separation of myelin layers seems to be the main contributor of these transient changes.^13,14,32 Oster et al³³ suggested that reversible restricted diffusion in the SCC is due to transient disruption of energy metabolism and ionic transport, causing reversible myelin vacuolization or intramyelinic edema. Furthermore, autopsy studies of patients with serious neurologic complications have shown that the acute reactive changes, such as congestion and hyperemia without inflammatory infiltration,^25,28,34 are more frequent than demyelination^34,35 and neuronal degeneration.³⁶

As stated by Tada et al,¹⁴ another possible mechanism of transient ADC reduction of SCC is the influx of inflammatory cells and macromolecules, combined with related cytotoxic edema, similar to the changes occurring in multiple sclerosis plaques.³⁷ The transient nature of the lesions suggests that the effect of virus on brain, either inflammatory or edematous, is reversible and may be the only detectable change in patients with good prognosis, a sign of clinically mild encephalitis/encephalopathy.

Differential diagnosis of lesions involving the SCC includes ischemia, infections, posterior reversible encephalopathy syndrome, diffuse axonal injury, multiple sclerosis, hydrocephalus, Marchiafava-Bignami disease, adrenoleukodystrophy, AIDS dementia complex, lymphoma, epilepsy, and antiepileptic drug usage.^{13,31,33,38–42} The transient feature of the lesion and other clinical and laboratory findings allow one to differentiate the infectious causes from others, but it is not easy to presume the exact infectious agent by clinical and radiologic findings. In latter situation, various infectious agents including influenza,¹³ rotavirus,¹⁵ measles,¹⁶ herpesvirus 6,¹⁷ Salmonella organisms,¹⁸ mumps,¹⁴ varicella-zoster virus,¹⁴ adenovirus,¹⁴ E coli,¹⁹ and Legionnaires’ disease²⁰ should be considered in the differential diagnosis.

Another challenging issue is the increased vulnerability of the SCC. Anatomic studies dealing with the corpus callosum demonstrate neither different fiber attenuation nor principally fiber composition in the SCC, compared with other regions of the corpus callosum.^43,44 Although the SCC has an arterial supply from the vertebrobasilar system, contrary to other parts of the corpus callosum supplied by the carotid system,⁴⁵ the absence of any signal-intensity change in the same vascular territory eliminates the vascular etiology.^13,14 The special affinity of the receptors on splenial axons or surrounding myelin sheaths to viral antigens or receptors on the antibodies induced by the antigens, expressed by elevated cytokines, can be the cause of this vulnerability, but this theory of Tada et al¹⁴ has lack of pathologic correlation. The exact reason for increased predilection of the SCC is still unclear and needs further animal and human research, but it probably remains in debate because of lack of pathologic confirmation of such transient lesions in humans.

The major drawbacks of this study are the lack of histopathologic correlation and low sampling numbers. Rapid resolution of clinical and radiologic findings prevents the biopsy requirement. The rare occurrence of IAEE is the natural cause of the low sampling number.

Conclusion

Although transient ADC reduction of SCC is not pathognomonic for IAEE, it is usually seen in patients with good prognosis, indicating a clinically mild form of encephalitis/encephalopathy. It is more likely due to intramyelinic edema or an inflammatory infiltrate of the SCC rather than a breakdown of the BBB or demyelination. Lack of pathologic correlation in such transient lesions does not allow us to identify the exact nature and pathogenesis of these lesions. Increasing numbers of such cases in the literature allow us to achieve a more reliable conclusion.

References

↵
Studahl M. Influenza virus and CNS manifestations. J Clin Virol 2003;28:225–32
CrossRef PubMed
↵
Yoshikawa H, Yamazaki S, Watanabe T, et al. Study of influenza-associated encephalitis/encephalopathy in children during the 1997–2001 influenza seasons. J Child Neurol 2001;16:885–90
Abstract/FREE Full Text
↵
Sugaya N. Influenza-associated encephalopathy in Japan: pathogenesis and treatment. Pediatr Int 2000;42:215–18
CrossRef PubMed
↵
Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood. Lancet 1963;91:749–52
CrossRef PubMed
↵
Levin M, Hjelm M, Kay JD, et al. Haemorrhagic shock and encephalopathy: a new syndrome with a high mortality in young children. Lancet 1983;2:64–67
CrossRef PubMed
↵
Davis LE. Diagnosis and treatment of acute encephalitis. Neurologist 2000;6:145–59
CrossRef
Mizuguchi M, Abe J, Mikkaichi K, et al. Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry 1995;58:555–61. Comment in: J Neurol Neurosurg Psychiatry 1995; 59:661 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=7500117&itool=pubmed_docsum
Abstract/FREE Full Text
↵
Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalence in Japan and Taiwan. Brain Dev 1997;19:81–92
CrossRef PubMed
↵
Okabe N, Yamashita K, Taniguchi K, et al. Influenza surveillance system of Japan and acute encephalitis and encephalopathy in the influenza season. Pediatr Int 2000;42:187–91
CrossRef PubMed
↵
Steininger C, Popow-Kraupp T, Laferl H, et al. Acute encephalopathy associated with influenza A virus infection. Clin Infect Dis 2003;36:567–74
Abstract/FREE Full Text
Kimura S, Ohtsuki N, Nezu A, et al. Clinical and radiological variability of influenza-related encephalopathy or encephalitis. Acta Paediatr Jpn 1998;40:264–70
PubMed
↵
Tokunaga Y, Kira R, Takemoto M, et al. Diagnostic usefulness of diffusion-weighted magnetic resonance imaging in influenza-associated acute encephalopathy or encephalitis. Brain Dev 2000;22:451–53
CrossRef PubMed
↵
Takanashi J, Barkovich AJ, Yamaguchi K, et al. Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. AJNR Am J Neuroradiol 2004;25:798–802
Abstract/FREE Full Text
↵
Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 2004;63:1854–58
Abstract/FREE Full Text
↵
Kobata R, Tsukahara H, Nakai A, et al. Transient MR signal changes in the splenium of the corpus callosum in rotavirus encephalopathy: value of diffusion-weighted imaging. J Comput Assist Tomogr 2002;26:825–28
CrossRef PubMed
↵
Mito Y, Yoshida K, Kikuchi S. Measles encephalitis with peculiar MRI findings: report of two adult cases [in Japanese]. Neurol Med 2002;56:251–56
↵
Kato Z, Kozawa R, Hashimoto K, et al. Transient lesion in the splenium of the corpus callosum in acute cerebellitis. J Child Neurol 2003;18:291–92
Abstract/FREE Full Text
↵
Kobuchi N, Tsukahara H, Kawamura Y, et al. Reversible diffusion-weighted MR findings of Salmonella enteritidis–associated encephalopathy. Eur Neurol 2003;49:182–84
CrossRef PubMed
↵
Ogura H, Takaoka M, Kishi M, et al. Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol 1998;19:1144–45
Abstract
↵
Morgan JC, Cavaliere R, Juel VC. Reversible corpus callosum lesion in Legionnaires’ disease. J Neurol Neurosurg Psychiatry 2004;75:651–54
Abstract/FREE Full Text
↵
Kizilkilic O, Karaca S. Influenza-associated encephalitis-encephalopathy with a reversible lesion in the splenium of the corpus callosum: case report and literature review [letter]. AJNR Am J Neuroradiol 2004;25:1863–64
FREE Full Text
↵
Ryan MM, Procopis PG, Ouvrier RA. Influenza A encephalitis with movement disorder. Pediatr Neurol 1999;21:669–73
CrossRef PubMed
↵
Yokota S, Imagawa T, Miyamae T, et al. Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr Int 2000;42:197–203
CrossRef PubMed
↵
Reinacher M, Bonin J, Narayan O, et al. Pathogenesis of neurovirulent influenza A virus infection in mice. Lab Invest 1983;49:686–92
PubMed
↵
Takahashi M, Yamada T, Nakashita Y, et al. Influenza virus-induced encephalopathy: clinicopathologic study of an autopsied case. Pediatr Int 2000;42:204–14
CrossRef PubMed
↵
Lehmann NI, Gust ID. Viremia in influenza: a report of two cases. Med J Aust 1971;2:1166–69
PubMed
↵
Xu H, Yasui O, Tsuruoka H, et al. Isolation of type B influenza virus from the blood of children. Clin Infect Dis 1998;27:654–55
FREE Full Text
↵
Frankova V, Jirasek A, Tumova B. Type A influenza: postmortem virus isolations from different organs in human lethal cases. Arch Virol 1977;53:265–58
CrossRef PubMed
↵
Ito Y, Ichiyama T, Kimura H, et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol 1999;58:420–25
CrossRef PubMed
↵
Doherty MJ, Jayadev S, Watson NF, et al. Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol 2005;62:433–37
CrossRef PubMed
↵
Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 2001;70:459–63. Comment in: Psychiatry Clin Neurosci 2003;57:550–51 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=12950714&itool=pubmed_docsum
Abstract/FREE Full Text
↵
Engelbrecht V, Scherer A, Rassek M, et al. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology 2002;222:410–18
PubMed
↵
Oster J, Doherty C, Grant PE, et al. Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia 2003;44:852–54
CrossRef PubMed
↵
Flewett TH, Hoult JG. Influenzal encephalopathy and postinfluenzal encephalitis. Lancet 1958;2:11–15
PubMed
↵
Horner FA. Neurologic disorders after Asian influenza. N Engl J Med 1958;258:983–85
PubMed
↵
Kapila CC, Kaul S, Kapur SC, et al. Neurological and hepatic disorders associated with influenza. Br Med J 1958;5108:1311–14
↵
Roychowdhury S, Maldjian JA, Grossman RI. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. AJNR Am J Neuroradiol 2000;21:869–74
Abstract/FREE Full Text
↵
Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 1999;20:125–29
Abstract/FREE Full Text
Prilipko O, Delavelle J, Lazeyras F, et al. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia 2005;46:1633–36
CrossRef PubMed
Tennison M. Focal lesion in the splenium of corpus callosum in epileptic patients: antiepileptic drug toxicity? [commentary] AJNR Am J Neuroradiol 1999;20:131–32
PubMed
Friese SA, Bitzer M, Freudenstein D, et al. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 2000;42:795–802
CrossRef PubMed
↵
Bourekas EC, Varakis K, Bruns D, et al. Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. AJR Am J Roentgenol 2002;179:251–57
CrossRef PubMed
↵
Aboitiz F, Scheibel AB, Fisher RS, et al. Fiber composition of the human corpus callosum. Brain Res 1992;558:143–53
↵
Highley JR, Esiri MM, McDonald B, et al. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 1999;122:99–110
Abstract/FREE Full Text
↵
Kakou M, Velut S, Destrieux C. Vascularisation artérielle et veineuse du corps calleux. Neurochirurgie 1998;4(suppl 1):31–37

Received December 15, 2005.
Accepted after revision January 25, 2006.

View Abstract

In this issue

Download PDF

Email Article

Citation Tools

Cited By...

More in this TOC Section

Show more BRAIN

[1] ↵
Studahl M. Influenza virus and CNS manifestations. J Clin Virol 2003;28:225–32
CrossRef PubMed

[2] ↵
Yoshikawa H, Yamazaki S, Watanabe T, et al. Study of influenza-associated encephalitis/encephalopathy in children during the 1997–2001 influenza seasons. J Child Neurol 2001;16:885–90
Abstract/FREE Full Text

[3] ↵
Sugaya N. Influenza-associated encephalopathy in Japan: pathogenesis and treatment. Pediatr Int 2000;42:215–18
CrossRef PubMed

[4] ↵
Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood. Lancet 1963;91:749–52
CrossRef PubMed

[5] ↵
Levin M, Hjelm M, Kay JD, et al. Haemorrhagic shock and encephalopathy: a new syndrome with a high mortality in young children. Lancet 1983;2:64–67
CrossRef PubMed

[6] ↵
Davis LE. Diagnosis and treatment of acute encephalitis. Neurologist 2000;6:145–59
CrossRef

[7] Mizuguchi M, Abe J, Mikkaichi K, et al. Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry 1995;58:555–61. Comment in: J Neurol Neurosurg Psychiatry 1995; 59:661 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=7500117&itool=pubmed_docsum
Abstract/FREE Full Text

[8] ↵
Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalence in Japan and Taiwan. Brain Dev 1997;19:81–92
CrossRef PubMed

[9] ↵
Okabe N, Yamashita K, Taniguchi K, et al. Influenza surveillance system of Japan and acute encephalitis and encephalopathy in the influenza season. Pediatr Int 2000;42:187–91
CrossRef PubMed

[10] ↵
Steininger C, Popow-Kraupp T, Laferl H, et al. Acute encephalopathy associated with influenza A virus infection. Clin Infect Dis 2003;36:567–74
Abstract/FREE Full Text

[11] Kimura S, Ohtsuki N, Nezu A, et al. Clinical and radiological variability of influenza-related encephalopathy or encephalitis. Acta Paediatr Jpn 1998;40:264–70
PubMed

[12] ↵
Tokunaga Y, Kira R, Takemoto M, et al. Diagnostic usefulness of diffusion-weighted magnetic resonance imaging in influenza-associated acute encephalopathy or encephalitis. Brain Dev 2000;22:451–53
CrossRef PubMed

[13] ↵
Takanashi J, Barkovich AJ, Yamaguchi K, et al. Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. AJNR Am J Neuroradiol 2004;25:798–802
Abstract/FREE Full Text

[14] ↵
Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 2004;63:1854–58
Abstract/FREE Full Text

[15] ↵
Kobata R, Tsukahara H, Nakai A, et al. Transient MR signal changes in the splenium of the corpus callosum in rotavirus encephalopathy: value of diffusion-weighted imaging. J Comput Assist Tomogr 2002;26:825–28
CrossRef PubMed

[16] ↵
Mito Y, Yoshida K, Kikuchi S. Measles encephalitis with peculiar MRI findings: report of two adult cases [in Japanese]. Neurol Med 2002;56:251–56

[17] ↵
Kato Z, Kozawa R, Hashimoto K, et al. Transient lesion in the splenium of the corpus callosum in acute cerebellitis. J Child Neurol 2003;18:291–92
Abstract/FREE Full Text

[18] ↵
Kobuchi N, Tsukahara H, Kawamura Y, et al. Reversible diffusion-weighted MR findings of Salmonella enteritidis–associated encephalopathy. Eur Neurol 2003;49:182–84
CrossRef PubMed

[19] ↵
Ogura H, Takaoka M, Kishi M, et al. Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol 1998;19:1144–45
Abstract

[20] ↵
Morgan JC, Cavaliere R, Juel VC. Reversible corpus callosum lesion in Legionnaires’ disease. J Neurol Neurosurg Psychiatry 2004;75:651–54
Abstract/FREE Full Text

[21] ↵
Kizilkilic O, Karaca S. Influenza-associated encephalitis-encephalopathy with a reversible lesion in the splenium of the corpus callosum: case report and literature review [letter]. AJNR Am J Neuroradiol 2004;25:1863–64
FREE Full Text

[22] ↵
Ryan MM, Procopis PG, Ouvrier RA. Influenza A encephalitis with movement disorder. Pediatr Neurol 1999;21:669–73
CrossRef PubMed

[23] ↵
Yokota S, Imagawa T, Miyamae T, et al. Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr Int 2000;42:197–203
CrossRef PubMed

[24] ↵
Reinacher M, Bonin J, Narayan O, et al. Pathogenesis of neurovirulent influenza A virus infection in mice. Lab Invest 1983;49:686–92
PubMed

[25] ↵
Takahashi M, Yamada T, Nakashita Y, et al. Influenza virus-induced encephalopathy: clinicopathologic study of an autopsied case. Pediatr Int 2000;42:204–14
CrossRef PubMed

[26] ↵
Lehmann NI, Gust ID. Viremia in influenza: a report of two cases. Med J Aust 1971;2:1166–69
PubMed

[27] ↵
Xu H, Yasui O, Tsuruoka H, et al. Isolation of type B influenza virus from the blood of children. Clin Infect Dis 1998;27:654–55
FREE Full Text

[28] ↵
Frankova V, Jirasek A, Tumova B. Type A influenza: postmortem virus isolations from different organs in human lethal cases. Arch Virol 1977;53:265–58
CrossRef PubMed

[29] ↵
Ito Y, Ichiyama T, Kimura H, et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol 1999;58:420–25
CrossRef PubMed

[30] ↵
Doherty MJ, Jayadev S, Watson NF, et al. Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol 2005;62:433–37
CrossRef PubMed

[31] ↵
Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 2001;70:459–63. Comment in: Psychiatry Clin Neurosci 2003;57:550–51 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=12950714&itool=pubmed_docsum
Abstract/FREE Full Text

[32] ↵
Engelbrecht V, Scherer A, Rassek M, et al. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology 2002;222:410–18
PubMed

[33] ↵
Oster J, Doherty C, Grant PE, et al. Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia 2003;44:852–54
CrossRef PubMed

[34] ↵
Flewett TH, Hoult JG. Influenzal encephalopathy and postinfluenzal encephalitis. Lancet 1958;2:11–15
PubMed

[35] ↵
Horner FA. Neurologic disorders after Asian influenza. N Engl J Med 1958;258:983–85
PubMed

[36] ↵
Kapila CC, Kaul S, Kapur SC, et al. Neurological and hepatic disorders associated with influenza. Br Med J 1958;5108:1311–14

[37] ↵
Roychowdhury S, Maldjian JA, Grossman RI. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. AJNR Am J Neuroradiol 2000;21:869–74
Abstract/FREE Full Text

[38] ↵
Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 1999;20:125–29
Abstract/FREE Full Text

[39] Prilipko O, Delavelle J, Lazeyras F, et al. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia 2005;46:1633–36
CrossRef PubMed

[40] Tennison M. Focal lesion in the splenium of corpus callosum in epileptic patients: antiepileptic drug toxicity? [commentary] AJNR Am J Neuroradiol 1999;20:131–32
PubMed

[41] Friese SA, Bitzer M, Freudenstein D, et al. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 2000;42:795–802
CrossRef PubMed

[42] ↵
Bourekas EC, Varakis K, Bruns D, et al. Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. AJR Am J Roentgenol 2002;179:251–57
CrossRef PubMed

[43] ↵
Aboitiz F, Scheibel AB, Fisher RS, et al. Fiber composition of the human corpus callosum. Brain Res 1992;558:143–53

[44] ↵
Highley JR, Esiri MM, McDonald B, et al. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 1999;122:99–110
Abstract/FREE Full Text

[45] ↵
Kakou M, Velut S, Destrieux C. Vascularisation artérielle et veineuse du corps calleux. Neurochirurgie 1998;4(suppl 1):31–37

Main menu

User menu

Search

American Journal of Neuroradiology

Transient Splenial Lesion of the Corpus Callosum in Clinically Mild Influenza-Associated Encephalitis/Encephalopathy

Abstract